Dr. Leslie Cooper recently had a paper published in “Circulation”, an American Heart Association Journal, on “Myocarditis: Entering the Mainstream”. Read about the first description of myocarditis in 1837, to the…
In 1986, a group of 8 cardiac pathologists (who were known as the Dallas Panel), made an attempt to establish uniform criteria for the diagnosis of myocarditis in heart biopsy…
As Rare Disease Day approaches on February 29th, it’s a moment for reflection, awareness, and most importantly, unity. In the vast landscape of medical conditions, some are so rare that…
Due to the Pre-Clinical Data and Initial Clinical Data from Cardiol’s Maverick-Pilot Phase II Study of Pericarditis, it has been granted Orphan Drug Designation for its lead drug candidate for…
Welcome to the Myocarditis Foundation’s educational resource aimed at shedding light on a commonly misunderstood cardiac condition: pericarditis. We share a YouTube video created by Zero to Finals, designed to…
We are thrilled to share some exciting news with you! Once again, the Myocarditis Foundation has achieved the prestigious Platinum Transparency Certification from Candid (formerly GuideStar), a leading non-profit reporting…
It’s been 11 years since the Kirsch Family have lost their youngest son, Quinn, suddenly to Viral Myocarditis. Living on Minnesota, he loved to play ice hockey with his 3…
Cardiogenic shock (CS) is a low cardiac output state resulting in tissue hypoxia and life threatening end-organ hypoperfusion. Despite growing cardiogenic shock research in adults, the epidemiology, clinical features, and…
First, I would like to introduce Dr. Dor Lotan. He is a heart failure cardiologist who specializes in advanced heart failure therapies and cardiomyopathies. He has a special interest in…
Our second 2023 Fellowship Grants was awarded to Dr. Simon Vanhentenrijk, MD, Pharm D, of the Cleveland Clinc for his work on: “Leveraging Cutting-edge PHlP-Seq Antibody Profiling to Differentiate Autoantibody…
